169 related articles for article (PubMed ID: 2975225)
1. Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands.
Mansbach RS; Geyer MA
Eur J Pharmacol; 1988 Nov; 156(3):375-83. PubMed ID: 2975225
[TBL] [Abstract][Full Text] [Related]
2. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.
Davis M; Cassella JV; Kehne JH
Psychopharmacology (Berl); 1988; 94(1):14-20. PubMed ID: 2894698
[TBL] [Abstract][Full Text] [Related]
3. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.
Gilbert F; Dourish CT
Psychopharmacology (Berl); 1987; 93(3):349-52. PubMed ID: 2893412
[TBL] [Abstract][Full Text] [Related]
4. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
5. Acoustic startle, conditioned startle potentiation and the effects of 8-OH-DPAT and buspirone in rats selectively bred for differences in 8-OH-DPAT-induced hypothermia.
McQueen DA; Overstreet DH; Ardayfio PA; Commissaris RL
Behav Pharmacol; 2001 Nov; 12(6-7):509-16. PubMed ID: 11742145
[TBL] [Abstract][Full Text] [Related]
6. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by 8-hydroxy-2-(di-n-propylamino) tetralin and SM-3997, a novel anxiolytic drug, of the hippocampal rhythmical slow activity mediated by 5-hydroxytryptamine1A receptors.
Hirose A; Tsuji R; Shimizu H; Tatsuno T; Tanaka H; Kumasaka Y; Nakamura M
Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):8-13. PubMed ID: 1969119
[TBL] [Abstract][Full Text] [Related]
8. Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics.
Cunningham KA; Callahan PM; Appel JB
Eur J Pharmacol; 1987 Jun; 138(1):29-36. PubMed ID: 2887435
[TBL] [Abstract][Full Text] [Related]
9. Rapid discrimination of the stimulus properties of 5-hydroxytryptamine agonists using conditioned taste aversion.
Lucki I
J Pharmacol Exp Ther; 1988 Dec; 247(3):1120-7. PubMed ID: 2974486
[TBL] [Abstract][Full Text] [Related]
10. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
11. Reversal of helpless behavior in rats by putative 5-HT1A agonists.
Giral P; Martin P; Soubrié P; Simon P
Biol Psychiatry; 1988 Feb; 23(3):237-42. PubMed ID: 2892540
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex.
Rigdon GC; Weatherspoon JK
J Pharmacol Exp Ther; 1992 Nov; 263(2):486-93. PubMed ID: 1432685
[TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus properties of the serotonergic compound eltoprazine.
Ybema CE; Slangen JL; Olivier B; Mos J
J Pharmacol Exp Ther; 1992 Mar; 260(3):1045-51. PubMed ID: 1532031
[TBL] [Abstract][Full Text] [Related]
14. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
Gilbert F; Dourish CT; Brazell C; McClue S; Stahl SM
Psychoneuroendocrinology; 1988; 13(6):471-8. PubMed ID: 2907164
[TBL] [Abstract][Full Text] [Related]
15. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.
Gilbert F; Brazell C; Tricklebank MD; Stahl SM
Eur J Pharmacol; 1988 Mar; 147(3):431-9. PubMed ID: 2897920
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of 5HT1A receptors induces lower lip retraction in the rat.
Berendsen HH; Jenck F; Broekkamp CL
Pharmacol Biochem Behav; 1989 Aug; 33(4):821-7. PubMed ID: 2533357
[TBL] [Abstract][Full Text] [Related]
17. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
Söderpalm B; Hjorth S; Engel JA
Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
[TBL] [Abstract][Full Text] [Related]
18. Enhancement by the putative 5-HT receptor agonist 8-OH-2-(di-n-propylamino)tetralin of the acoustic startle response in the rat.
Svensson L; Ahlenius S
Psychopharmacology (Berl); 1983; 79(2-3):104-7. PubMed ID: 6221350
[TBL] [Abstract][Full Text] [Related]
19. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
20. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
